The protein, known as QP509L, was investigated by a team of researchers at the College of Veterinary Medicine of Chungnam National University in Daejeon, Republic of Korea, led by corresponding author Jong-Soo Lee. Their work reveals that QP509L functions as what the authors describe as a dual-targeted molecular breaker of innate immunity. Rather than blocking a single immune pathway, the protein interferes both with the STING pathway, which detects viral DNA inside the cell, and with the JAK-STAT signaling axis, which carries the interferon alarm from the cell surface to the nucleus. The finding provides a mechanistic explanation for the remarkable ability of African swine fever virus to neutralize type I interferon responses, the body’s first chemical line of defense against viral infection.

To appreciate the significance of the discovery, it helps to understand how the two pathways work. When a virus replicates inside a cell, fragments of its DNA can leak into the cytoplasm, where they are detected by a sensor called cGAS. This sensor triggers the production of a small messenger molecule that activates STING, a protein resident on the endoplasmic reticulum. Once activated, STING must physically travel from the endoplasmic reticulum to the ER-Golgi intermediate compartment, a journey powered by the cell’s COPII vesicle transport machinery, before it can recruit and activate the kinases TBK1 and the transcription factor IRF3. Only after this trafficking step can the cell begin producing interferon, the soluble signal that warns neighboring cells that a virus is on the loose.

The Korean team found that QP509L shuts down this process at its most vulnerable juncture: the journey itself. Through detailed molecular interaction assays, they showed that QP509L binds to the C-terminal region of STING, a segment containing two specific amino acid residues, leucine 333 and arginine 334. This binding interferes with the association between STING and Sec24C, a core component of the COPII coat protein complex that loads cargo into transport vesicles. With Sec24C unable to engage STING properly, the activated sensor becomes stranded near the endoplasmic reticulum and cannot complete its anterograde trafficking to the ER-Golgi intermediate compartment. The consequence is a bottleneck that starves the downstream signaling machinery of its key activator.

The functional outcome of this trafficking blockade is exactly what one would predict. With STING immobilized, the recruitment and activation of TBK1 are diminished, and in turn the phosphorylation and activation of IRF3 are reduced, dampening the transcriptional program that drives interferon production. The researchers also observed that the trafficking defect altered STING-associated autophagic responses, suggesting that QP509L may interfere not only with interferon induction but also with the related cellular processes that help degrade viral components. In effect, the viral protein does not merely muffle the alarm; it prevents the alarm from ever being delivered to the right room in the first place.

But QP509L does not stop there. Even if a cell manages to produce some interferon, that signal must still be received and translated into action by neighboring cells, and this is where the second arm of the protein’s sabotage comes into play. Interferon binds to receptors on the cell surface and activates the JAK-STAT pathway, culminating in the phosphorylation of STAT1 at a specific tyrosine residue, tyrosine 701. Phosphorylated STAT1 teams up with STAT2 and a third protein called IRF9 to form a complex known as interferon-stimulated gene factor 3, or ISGF3. This complex travels into the nucleus and switches on hundreds of interferon-stimulated genes, the biochemical arsenal that renders cells resistant to viral replication.

The study demonstrates that QP509L targets this pathway as well, binding to the C-terminal transactivation domain of STAT1. By occupying this region, the viral protein reduces the phosphorylation of STAT1 at tyrosine 701, a modification that is essential for the assembly of the ISGF3 complex. With STAT1 insufficiently phosphorylated, the heterotrimeric ISGF3 complex fails to assemble properly and cannot be imported into the nucleus at normal levels. The result is that even when interferon is present in the extracellular environment, the cell’s genetic response to it is blunted, leaving the virus freer to replicate with less molecular resistance.

Perhaps the most compelling evidence for the physiological relevance of these findings comes from experiments performed during actual infection with a pathogenic strain of African swine fever virus. When the researchers used small interfering RNA to knock down QP509L expression during infection, the host cell’s antiviral gene expression was restored. This loss-of-function experiment demonstrates that QP509L is not merely capable of interfering with immune signaling in artificial overexpression systems; it actively performs this suppression during the course of a real infection, making it a genuine virulence factor rather than a laboratory curiosity.

The timing of QP509L’s expression adds an additional layer of interest. The gene is transcribed early during infection, yet the protein itself behaves as a late product. This temporal pattern suggests that the virus may stockpile the transcript in preparation for a later phase of the replication cycle, when large amounts of viral DNA accumulate in the cytoplasm and the STING pathway would otherwise be maximally triggered. By deploying its dual-function antagonist at precisely the moment when the cell’s DNA-sensing machinery and interferon amplification loop would converge, the virus ensures that both the sensor and the responder are neutralized in a coordinated fashion.

The implications for disease control are potentially significant. African swine fever has devastated pig populations across Asia, Europe, and beyond, and the absence of an effective vaccine owes much to the difficulty of attenuating a virus that carries so many overlapping immune evasion functions. By identifying QP509L as a central node in that evasion network, and by pinpointing the specific molecular interfaces it exploits, including the L333 and R334 residues on STING and the transactivation domain of STAT1, the study offers concrete targets for rational attenuation. A virus engineered to lack or disable QP509L would be expected to reveal itself far more readily to the innate immune system, a strategy that has proven successful for vaccine development against other pathogens. The authors propose QP509L as a promising candidate for such future attenuation strategies, and the open-access publication ensures that researchers worldwide can build on the finding. As the global swine industry continues to absorb the enormous economic costs of this disease, understanding the molecular saboteurs that make the virus so lethal represents an essential step toward the vaccines and therapeutics that farmers desperately need.

Subject of Research: Mechanism by which African swine fever virus protein QP509L suppresses STING and STAT1 innate immune signaling

Article Title: African swine fever virus QP509L acts as a dual-targeted molecular breaker of innate immunity by interfering with STING trafficking and STAT1-dependent signaling

Article References: African swine fever virus QP509L acts as a dual-targeted molecular breaker of innate immunity by interfering with STING trafficking and STAT1-dependent signaling. (n.d.). https://doi.org/10.1007/s00018-026-06484-8

Image Credits: AI Generated

DOI: 10.1007/s00018-026-06484-8

Keywords: African swine fever virus, QP509L, innate immunity, STING, interferon, JAK-STAT, STAT1, ISGF3, COPII trafficking, antiviral defense, viral immune evasion, swine disease